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Background. There has been little focus on the quality of care provided in the prevention of mother-to-child transmission 
(PMTCT) of HIV services in South Africa (SA). 
Objective. To assess the quality of care in PMTCT services in Soweto, SA, focusing on the knowledge and experiences of 
healthcare workers and HIV-infected pregnant women accessing the services.
Methods. A cross-sectional survey was conducted in November - December 2009. A total of 201 HIV-infected pregnant women 
and 80 healthcare workers from 10 antenatal clinics were interviewed using standardised questionnaires.
Results. Among the HIV-infected pregnant women, the median gestational age was 20 weeks at the first antenatal visit and 32 
weeks at the time of the interview. The majority of the women interviewed (71.5%) discovered that they were HIV-infected in 
the index pregnancy, and 87.9% disclosed their HIV status. Overall, 97.5% received counselling and 33.5% were members of a 
support group. Knowledge of antenatal and intra-partum PMTCT interventions was accurate in 62.7% and 43.3% of the women, 
respectively. Support group membership and current use of antiretroviral prophylaxis did not impact on the quality of knowledge. 
Of the healthcare workers, 43.8% were professional nurses and 37.5% were lay counsellors. The majority (80.0%) felt satisfied with 
their knowledge of the PMTCT guidelines and 96.3% felt competent in managing HIV-infected pregnant women. Yet, there were 
important deficiencies in the knowledge of the guidelines. 
Conclusion. In our study, the knowledge of PMTCT interventions was low in both clients and healthcare workers. This 
points to the need to improve quality of care in PMTCT services, especially with increasingly complex PMTCT interventions 
recommended by international policies.
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In the past few years, South Africa (SA) has 
made significant progress in the provision of 
prevention of mother-to-child transmission 
(PMTCT) of HIV services, both in the delivery 
of more efficacious PMTCT interventions and 
also an increase in the proportion of women receiving the 
interventions.[1] According to a UNAIDS report, ~95% of HIV-
infected pregnant women in SA received some antiretroviral 
therapy (ART) intervention for PMTCT in 2010.[2] While 
progress has been made, there are still several challenges in 
scaling up PMTCT services in the SA public healthcare sector. 
These relate to coverage at different steps of the PMTCT 
cascade, and also to the quality of care rendered in the services. 
According to a qualitative study documenting women’s 
experiences of accessing ART and PMTCT programmes in 
several facilities in SA, health system weaknesses impacted 
negatively on access.[3]
Healthcare system and patient factors are important in 
the scale-up and success of HIV programmes (including 
PMTCT) [4-7] and the availability of interventions alone is 
not sufficient to guarantee appropriate implementation and 
uptake.[4-5,8-9] Healthcare facilities need to be well-resourced 
with competent and motivated staff to provide the services, 
and there needs to be service uptake and treatment adherence 
by patients.[4-7] The providers’ and patients’ knowledge and 
attitudes are also important.[7,8] There is evidence to suggest 
that the patient-provider relationship may have an effect on 
decision-making during the antenatal period, and on the 
uptake of PMTCT interventions.[10] Yet, quality of care has 
not been a focus in most PMTCT services in SA; most are 
focused on increasing coverage in the PMTCT cascade. Several 
reviews have found poor performance and coverage in PMTCT 
programmes, despite the simplicity of some interventions; 
hence, the focus has been on increasing coverage.[5,11,12]
We conducted a cross-sectional survey to investigate key 
aspects of the quality of care in PMTCT services in antenatal 
clinics in Soweto, SA, focusing on the PMTCT programme 
knowledge and experiences of (i) healthcare workers and (ii) 
HIV-infected pregnant women accessing the services. This 
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PMTCT guidelines in 2008, when zidovudine 
(AZT) monotherapy became available for 
prophylaxis.[13] 
Methods 
The study was approved by the Human 
Research Ethics Committee of the University 
of the Witwatersrand. All participants signed 
written informed consent to participate.
Until March 2008, all antenatal clinics in 
Soweto had only intrapartum single-dose 
nevirapine (NVP) for PMTCT for pregnant 
women who were not eligible for life-long 
ART. AZT was rolled out in phases across the 
antenatal clinics in March - October 2008. 
Prior to implementation of the guidelines, 
staff at the antenatal clinics, including lay 
counsellors, were trained on the new 
guidelines. The PMTCT service at each clinic 
was staffed by a professional nurse – a ‘PMTCT 
co-ordinator’ in charge of PMTCT services, 
including supervision of lay counsellors. 
The study was conducted in November - 
December 2009; all facilities had at least 12 
months of routine services under the 2008 
PMTCT guidelines. Participating clinics were a 
mixture of low- and high-volume clinics, with 
50 - 300 pregnant women presenting to each 
clinic per month. The HIV prevalence was 29% 
in 2009, and 15 - 20% of pregnant women were 
eligible for ART under the guidelines in place at 
the time (criterion: CD4+ count ≤200 cells/μl).
HIV-infected pregnant women
Using consecutive sampling, ART-eligible 
and -ineligible HIV-infected pregnant women 
presenting to the selected antenatal clinics for 
repeat visits were interviewed using a structured 
questionnaire. Their experiences of being 
HIV-infected and their knowledge of available 
PMTCT interventions were determined. Eight 
key-knowledge questions were selected; each 
was assigned a score of 1 for a correct answer and 
0 for an incorrect answer (maximum score of 8). 
Healthcare workers
Healthcare workers from the same clinics were 
interviewed using a different questionnaire 
assessing their opinions and experiences 
of working in a PMTCT programme and 
their knowledge of the PMTCT guidelines. 
Consecutive sampling was used to select 
participants. Similar to the knowledge score 
devised for patients, a scoring system based 
on eight key questions was formulated. 
All interviewers received training on the 
questionnaire, and all were fluent in the local 
vernacular languages. 
Data analysis
Data were analysed using Stata version 12.0. 
Descriptive statistics used employed means 
and standard deviations (SDs) or medians and 
interquartile ranges (IQRs) (for continuous 
variables) and proportions (for categorical 
variables). We compared knowledge scores on 
subgroups using Student’s t-tests and Fisher’s 




A total of 201 HIV-infected pregnant women 
were interviewed (Table 1). The mean age 
was 27.7 years (SD ±4.8); median gestational 
age was 20 weeks (IQR 16 - 24) at the first 
antenatal visit and 32 weeks (IQR 24 - 32) 
at the time of the interview. The majority of 
women (71.5%) discovered that they were 
HIV-infected in the index pregnancy. Of the 
women diagnosed in a previous pregnancy, 
84.1% (37/44) had previously taken single-
dose NVP for PMTCT. A baseline CD4+ 
cell count was available for 92.0% of the 
participants: median 395 cells/μl (IQR 294 - 
500); mean 420 cells/μl (SD ±190).
Overall, 87.5% (175/200) of the women had 
disclosed their HIV status; the majority (90.9%; 
159/175) had done so to their partners. This 
finding did not differ according to timing of HIV 
diagnosis. Of the women who discovered that 
they were HIV-infected in the index pregnancy, 
68.0% had disclosed their status. There were 
various reasons for non-disclosure to the 
partner, including fear that the partner would 
leave, be violent, or accuse the woman of being 
unfaithful and infecting him with HIV. Less than 
half (45.3%) of the women knew their partner’s 
HIV status. There was a significant difference 
in the knowledge of the partner’s HIV status 
between women who had, and those who had 
not disclosed their HIV status: 89 (50.9%) v. 0 
(0%) knew the partner’s HIV status, respectively 
(p<0.001). Of the partners with known HIV 
status, 81.3% were HIV-infected. 
Of the women, 62.7% and 43.3% had 
accurate knowledge on antenatal and intra-
partum prophylaxis, respectively. Overall, 
97.5% (196/201) had received some 
counselling, 67.7% had received more than 
one counselling session, 88.6% (178/201) 
felt that the time spent on counselling was 
adequate, and 33.5% were part of a support 
group. There was no significant difference in 
knowledge between pregnant women who 
were members of a support group (mean 
score 5.29; SD ±0.98)), and those who were 
not (mean score 5.18; SD ±1.41) (p=0.542) 
(Table 2). There was a significant difference in 
knowledge between women who were already 
receiving AZT prophylaxis (mean score 5.44; 
SD ±1.18) and those who were not (mean 
score 4.94; SD ±1.34) (Table 3) (p=0.005).
Table 1. Characteristics of pregnant women (N=201)
Characteristics 
Age (years), mean (±SD) 27.7 (±4.8)
Parity, median (IQR) 2 (1 - 2)
Gravidity, median (IQR) 2 (1 - 3)
Gestational age at booking (weeks), median (IQR) 20 (16 - 24)
Gestational age at interview (weeks), median (IQR) 32 (24 - 32)
CD4+ cell count (cells/μl), median (IQR) 395 (294 - 500)
When HIV status discovered (N=200)
Current pregnancy 143 (71.5)
Previous pregnancy 44 (22.0)
Outside of pregnancy 13 (6.5)
Disclosed HIV status (N=199), n (%) 175 (87.9)
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Healthcare workers 
Of the healthcare workers interviewed, 43.8% 
were professional nurses and 37.5% were lay 
counsellors; the majority (81.3%) had been 
in their current position for longer than 
a year (Table 4). Less than a half (47.5%) 
were satisfied with their working conditions. 
The most dissatisfaction was in terms of 
remuneration; only 28.8% were satisfied with 
their salary. In terms of workload, 80.0% 
of the workers felt that the new PMTCT 
programme increased their workload, and 
92.5% felt that there was a need for more staff 
for the programme.
Most healthcare workers were satisfied with 
their knowledge of the PMTCT guidelines 
(80.0%) and with their general knowledge 
of HIV/AIDS (91.3%). In managing HIV-
infected pregnant women, 96.3% were 
satisfied with their competence. Training 
received on the new guidelines was perceived 
to be adequate by 63.6%. The mean score 
for the workers’ knowledge of the PMTCT 
guidelines was 5.15 (SD ±1.85): 5.41 (SD 
±1.56) for professional nurses v. 5.19 (SD 
±1.89) for lay counsellors (p=0.586). There 
was no significant difference between the 
mean score of those who were satisfied with 
their knowledge of the guidelines (5.29; SD 
±1.88) and those who were not (4.56; SD 
±1.63) (p=0.157) (Table 5). There was also 
no difference between the mean score of 
healthcare workers who thought that the 
training they received was adequate (5.10; SD 
±1.9) and those who did not (5.14; SD ±1.7) 
(p=0.926).
Table 2. Characteristics and knowledge of pregnant women who were members of a support group (N=67) 
v. those who were not (N=133) 
















































Prophylaxis during labour 18 (26.9) 69 (51.9) 0.001
Need for infant prophylaxis 63 (94.0) 111 (83.5) 0.036
Type of infant prophylaxis 7 (10.5) 18 (13.5) 0.553
Duration of infant prophylaxis 52 (77.6) 62 (39.1) <0.001
Duration of exclusive breastfeeding 59 (88.1) 87 (65.4) 0.001
Overall score, mean (±SD) 5.3 (±0.98) 5.2 (±1.41) 0.542
AZT = zidovudine; SD = standard deviation.
Table 3. Difference in knowledge in pregnant women who were already on zidovudine (AZT) prophylaxis 







Indication for AZT 111 (97.4) 79 (91.9) 0.137
Timing of AZT initiation 101 (88.6) 82 (95.4) 0.125
Duration of use of AZT 79 (69.3) 47 (54.7) 0.034
Intrapartum prophylaxis 63 (55.3) 24 (27.9) <0.001
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A high percentage of healthcare workers 
(86.3%) thought that HIV-infected pregnant 
women did not disclose their HIV status. 
There were a number of adverse opinions 
about HIV-infected women having children: 
21.3% of healthcare workers thought that HIV-
infected individuals should not have children; 
53.8% thought HIV-infected individuals were 
having too many children; and 46.3% thought 
that social grants were an incentive for HIV-
infected women to have children. 
Discussion 
In this cross-sectional survey, several challenges 
were identified in the Soweto PMTCT 
programmes. The majority of pregnant women 
discovered that they were HIV-infected during 
pregnancy, and although disclosure to partners 
was high, less than half knew their partner’s HIV 
status. There were important deficiencies in the 





Professional nurse 35 (43.8)
Auxiliary nurse 9 (11.3)
Lay counsellor 30 (37.5)
Other 6 (7.5)
Time in current position
<6 months 7 (8.8)
6 months - 1 year 8 (10.0)
>1 - 5 years 33 (41.3)
>5 - 10 years 22 (27.5)
>10 years 10 (12.5)
Table 5. Characteristics and knowledge of healthcare workers who were satisfied with their knowledge of 
PMTCT (N=64) v. those who were not (N=16)







Midwife 14 (21.9) 6 (37.5)
PMTCT coordinator 10 (15.6) 0 (0)
PCR nurse 4 (6.1) 2 (12.5)
Lay counsellor 28 (43.8) 2 (12.5)
Other 8 (12.5) 6 (37.5)
Time in current position
<6 months 4 (6.3) 3 (18.8)
6 months - 1 year 7 (10.9) 1 (6.3)
2 - 5 years 30 (46.9) 3 (18.8)
6 - 10 years 19 (29.7) 3 (18.8)
>10 years 4 (6.3) 6 (37.5)
Correct knowledge 
Single-dose NVP
Efficacy 55 (85.9) 11 (68.8) 0.211
Repeat in same pregnancy 52 (81.3) 10 (62.5) 0.410
Use in subsequent pregnancies 51 (79.7) 12 (75.0) 0.933
ART use in pregnancy 44 (68.8) 8 (50.0) 0.191
Sero-conversion during pregnancy 42 (65.5) 10 (62.5) 0.754
Exclusive breastfeeding and risk of MTCT 26 (40.6) 9 (56.3) 0.190
Extended breastfeeding and risk of MTCT 50 (78.1) 12 (75.0) 0.704
Contraception for HIV-infected women 19 (29.7) 1 (6.3) 0.105
Overall score, mean (±SD) 5.3 (±1.88) 4.6 (±1.63) 0.157
PMTCT = prevention of mother-to-child transmission of HIV; PCR nurse = nurse responsible for HIV PCR tests in infants; NVP = nevirapine; ART = antiretroviral therapy; 
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women’s knowledge of the available PMTCT 
interventions, despite receiving counselling and 
their perception that the counselling that they 
received was adequate. Neither the number of 
counselling sessions received, nor participation 
in a support group, had an impact on the quality 
of knowledge. 
Staff in the PMTCT programme felt well 
prepared and well informed prior to the rollout 
of the updated PMTCT programme. The 
majority thought that the training received was 
adequate and almost all felt confident about 
managing HIV-infected women; yet, there 
were several important gaps in the knowledge 
of the PMTCT guidelines. Job satisfaction was 
low, mostly in terms remuneration. Moreover, 
several staff members expressed negative 
opinions about HIV-infected women having 
children. 
The findings of this cross-sectional survey 
have important implications for PMTCT 
programmes in SA. Routine HIV testing 
for women, and men, of reproductive age 
needs to be encouraged, and linkages to care 
provided for those who test HIV-positive. 
This is especially important in women who 
are ART-eligible, as they carry a high risk 
of mother-to-child transmission, and ART 
initiated preconception decreases this risk 
significantly.[14] It will be important to assess 
the impact of the SA national HIV counselling 
and testing (HCT) drive on testing outside of 
pregnancy.[15] 
Unpublished data from the Soweto PMTCT 
programmes indicate that the number of 
pregnant women presenting for antenatal care 
with a known HIV-positive status and already 
receiving ART has increased in the past 2 
years (C Mnyani, unpublished data). The rate 
of disclosure among HIV-infected pregnant 
women in this survey was higher than that 
reported for most of sub-Saharan Africa, 
but similar to the findings of another study 
conducted in SA.[16-18] Disclosure has been 
shown to be important in women’s uptake and 
adherence to PMTCT interventions.[16]
Our data on the women’s knowledge of 
PMTCT interventions suggest that the quality 
of counselling given can be improved. Incorrect 
information, and hence incorrect practices, will 
be harmful in the context of PMTCT and may 
significantly increase the risk of mother-to-
child transmission. While health knowledge is 
only one component of quality of care, there 
is evidence to suggest that poor quality of 
counselling, which translates to poor patient 
knowledge, is an important contributing factor 
to non-adherence to PMTCT interventions. [5,19] 
Poor quality of counselling has been 
reported even in well-functioning PMTCT 
sites where counsellors, some nurses, had 
received structured training. [20] The SA public 
healthcare sector depends on the services of 
lay counsellors who receive a stipend, and also 
receive variable training. Counselling services 
are often interrupted, and there is evidence 
to suggest that this has a negative effect on 
PMTCT services.[21] 
As we scale up PMTCT programmes and 
introduce more complex interventions, staff 
preparedness, including knowledge, needs to 
be improved.[22,23] There needs to be a review 
and standardisation of training providers, 
and also of training content. Support using 
trained peers who are experts in HIV care 
and management has been shown to be an 
important intervention in building capacity.[6] 
Negative staff attitudes towards HIV-infected 
women also need to be addressed. There is 
evidence that HIV-infected women who fear 
and/or experience stigmatisation may avoid 
participating in PMTCT programmes.[24] 
Study limitations
While our findings do have im portant 
implications, there are several limitations 
to this survey. Like all questionnaire-based 
research, the results may have been influenced 
by reporting biases. In this case, participants 
may have felt social desirability to report 
satisfaction with their PMTCT-related 
knowledge, but this potential bias was unlikely 
to have influenced their ability to report 
factual knowledge correctly. In addition, 
although the study was conduced under a 
different set of PMTCT policy guidelines, the 
findings are particularly noteworthy given the 
subsequent implementation of more complex 
PMTCT guidelines in SA and many other 
parts of Africa. The study was conducted in 
one urban community of high HIV prevalence 
and with established PMTCT services, and 
the results should be generalised to other 
settings with caution. Healthcare workers were 
generally reluctant to be interviewed, and this 
warrants further investigation. Also, we used 
a consecutive sampling strategy; although 
routine in this form of health services research, 
this may be more prone to bias than random 
sampling strategies. There are plans to perform 
a similar survey to assess experiences with, and 
knowledge of the latest SA PMTCT guidelines. 
Despite the limitations, there are strengths to 
the survey that warrant merit, including the 
large number of pregnant women and different 
categories of staff who were interviewed. 
Conclusion
There are still several challenges in PMTCT 
services. Most importantly, knowledge of 
PMTCT interventions is surprisingly low in 
both clients and healthcare providers, and 
there is a need for enhanced interventions 
to improve the quality of care in PMTCT 
services. This is particularly important as 
PMTCT interventions become more complex 
during the ante- and postnatal periods.
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